I am the first accountant at a startup and am seeking advice on how to handle legal fees incurred during the Series A financing process: should these fees be expensed directly or offset against Additional Paid-In Capital (APIC)? It should be noted that the company has previously issued common stock (mainly to founders and employees). Any professional advice on this issue would be greatly appreciated.

Background and Core Issue

In the financing cycle of a startup, the Series A round is a milestone step. Legal fees often constitute a significant cost component of this round. According to common practice under US GAAP and IFRS, incremental costs directly related to the issuance of equity can typically be offset against the proceeds from the issuance, i.e., recorded as a reduction in APIC; while legal fees of a general administrative nature should be expensed in the period incurred.

Key Judgment Factors

In practice, distinguishing between "direct incremental costs" and "general expenses" is the core. The following factors are worth considering:

• Direct relevance of the fees to the financing activity: For example, legal fees incurred for drafting investment agreements, due diligence, securities law compliance, etc., are typically considered direct incremental costs.
• Whether the fees were incurred before the completion of the financing and can be clearly attributed: If the fees were incurred during the negotiation or closing stage of the financing, and the contract clearly stipulates that the company bears them, they are more likely to qualify for offsetting against APIC.
• Whether the company has a record of issuing common stock: You mentioned that the company has issued common stock to founders and employees, which does not affect the treatment of Series A financing fees, but attention should be paid to distinguishing the attribution of fees across different financing rounds.

Accounting Impact of the Two Treatment Methods

If expensed, the legal fees will be recorded in the current period's profit or loss, reducing net income, but will not affect total shareholders' equity (except for income tax effects). If offset against APIC, the fees do not enter the income statement but directly reduce additional paid-in capital, thereby lowering the capital surplus component of shareholders' equity, but without affecting retained earnings.

It is worth noting that guidance from the U.S. Securities and Exchange Commission (SEC) and the Financial Accounting Standards Board (FASB) (such as ASC 340-10-S99) emphasizes that only those incremental costs "directly attributable to the issuance of stock" can be offset against issuance proceeds. If legal fees involve general corporate matters (such as amendments to the articles of incorporation, employee equity incentive plans, etc.), they must be expensed.

Practical Recommendations

Given that you are the first accountant, it is recommended to take the following steps:

1. Sort through the legal fee details, distinguishing between portions directly related to the Series A financing (such as investment agreements, shareholder agreements, offering documents, etc.) and general legal consultation fees.
2. Communicate with external auditors or financial advisors to confirm the consistency of the company's accounting policies.
3. If the fee amount is material, consider disclosing the treatment method and basis in the notes to the financial statements.

Finally, it should be noted that accounting standards in different jurisdictions (such as China and the United States) may have subtle differences, but the basic principles are similar. If the company plans to go public or undergo an audit in the future, it is advisable to reach a consensus with the audit firm in advance.

"Direct incremental costs" are the key to determining whether legal fees can be offset against APIC, but in practice, careful evaluation should be based on specific facts and contract terms.

I hope the above analysis is helpful to you. If further discussion is needed, please feel free to provide more details.